Our data corroborate recent observations by Li et al., who detected a reduced percentage and suppressive activity of Tregs in stroke patients, and extend their findings by demonstrating that functionally active CD39+ Tregs are predominantly reduced following stroke [28]. This evidence concerns the gene ENTPD1 and stroke disorder.